The Performance of Compartmental and Physiologically Based Recirculatory Pharmacokinetic Models for Propofol: A Comparison Using Bolus, Continuous, and Target-Controlled Infusion Data

BACKGROUND: With the growing use of pharmacokinetic (PK)-driven drug delivery and/or drug advisory displays, identifying the PK model that best characterizes propofol plasma concentration (Cp) across a variety of dosing conditions would be useful. We tested the accuracy of 3 compartmental models and 1 physiologically based recirculatory PK model for propofol to predict the time course of propofol Cp using concentration-time data originated from studies that used different infusion schemes. METHODS: Three compartmental PK models for propofol, called the “Marsh,” the “Schnider,” and the “Schüttler” models, and 1 physiologically based recirculatory model called the “Upton” model, were used to simulate the time course of propofol Cp. To test the accuracy of the models, we used published measured plasma concentration data that originated from studies of manual (bolus and short infusion) and computer-controlled (target-controlled infusion [TCI] and long infusion) propofol dosing schemes. Measured/predicted (M/P) propofol Cp plots were constructed for each dataset. Bias and inaccuracy of each model were assessed by median prediction error (MDPE) and median absolute prediction error (MDAPE), respectively. RESULTS: The M/P propofol Cp in the 4 PK models revealed bias in all 3 compartmental models during the bolus and short infusion regimens. In the long infusion, a worse M/P propofol Cp at higher concentration was seen for the Marsh and the Schüttler models than for the 2 other models. Less biased M/P propofol Cp was found for all models during TCI. In the bolus group, after 1 min, a clear overprediction was seen for all 3 compartmental models for the entire 5 min; however, this initial error resolved after 4 min in the Schnider model. The Upton model did not predict propofol Cp accurately (major overprediction) during the first minute. During the bolus and short infusion, the Marsh model demonstrated worse MDPE and MDAPE compared with the 3 other models. During short infusion, MDAPE for the Schnider and Schüttler models was better than the Upton and the Marsh models. All models showed similar MDPE and MDAPE during TCI simulations. During long infusion, the Marsh and the Schüttler models underestimated the higher plasma concentrations. CONCLUSION: When combining the performance during various infusion regimens, it seems that the Schnider model, although still not perfect, is the recommended model to be used for TCI and advisory displays.

[1]  P. Parkin,et al.  Severe hypertension and raised haematocrit: unusual presentation of Guillain-Barré syndrome. , 1985, Postgraduate medical journal.

[2]  H. Schwilden,et al.  Pharmacokinetic and pharmacodynamic modelling of propofol ('Diprivan') in volunteers and surgical patients. , 1985, Postgraduate medical journal.

[3]  M. White,et al.  Pharmacokinetics of propofol in female patients. Studies using single bolus injections. , 1987, British journal of anaesthesia.

[4]  E. Gepts,et al.  Disposition of Propofol Administered as Constant Rate Intravenous Infusions in Humans , 1987, Anesthesia and analgesia.

[5]  S L Shafer,et al.  Pharmacokinetics and Pharmacodynamics of Propofol Infusions during General Anesthesia , 1988, Anesthesiology.

[6]  E. J. Douglas,et al.  Pharmacokinetics of propofol (diprivan) in elderly patients. , 1988, British journal of anaesthesia.

[7]  C. Saint-Maurice,et al.  Pharmacokinetics of propofol in young children after a single dose. , 1989, British journal of anaesthesia.

[8]  M. Avram,et al.  Intravascular mixing and drug distribution: The concurrent disposition of thiopental and indocyanine green , 1989, Clinical pharmacology and therapeutics.

[9]  M. White,et al.  Intravenous propofol anaesthesia using a computerised infusion system , 1990, Anaesthesia.

[10]  M. White,et al.  Intravenous propofol anaesthesia using a computerised infusion system , 1990, Anaesthesia.

[11]  N. Morton,et al.  Pharmacokinetic model driven infusion of propofol in children. , 1991, British journal of anaesthesia.

[12]  M. Avram,et al.  Time-dependent distribution volume and kinetics of the pharmacodynamic effector site. , 1992, Journal of pharmaceutical sciences.

[13]  J. Glen,et al.  Pharmacokinetic model selection for target controlled infusions of propofol. Assessment of three parameter sets. , 1994 .

[14]  A. McEwan,et al.  The Interaction of Fentanyl on the Cp50 of Propofol for Loss of Consciousness and Skin Incision , 1994, Anesthesiology.

[15]  H F Nicodemus,et al.  The Pharmacokinetics of Propofol in Children Using Three Different Data Analysis Approaches , 1994, Anesthesiology.

[16]  J. Glen,et al.  Pharmacokinetic Model Selection for Target Controlled Infusions of Propofol: Assessment of Three Parameter Sets , 1994, Anesthesiology.

[17]  C A Shanks,et al.  Recirculatory pharmacokinetic models of markers of blood, extracellular fluid and total body water administered concomitantly. , 1996, The Journal of pharmacology and experimental therapeutics.

[18]  S. Daniels,et al.  Stroke volume and cardiac output in normotensive children and adults. Assessment of relations with body size and impact of overweight. , 1997, Circulation.

[19]  James H. Brown,et al.  A General Model for the Origin of Allometric Scaling Laws in Biology , 1997, Science.

[20]  R N Upton,et al.  A physiological model of induction of anaesthesia with propofol in sheep. 1. Structure and estimation of variables. , 1997, British journal of anaesthesia.

[21]  F S Servin,et al.  TCI compared with manually controlled infusion of propofol: a multicentre study , 1998, Anaesthesia.

[22]  C. Reilly,et al.  Evaluation of the predictive performance of a ‘Diprifusor’ TCI system , 1998, Anaesthesia.

[23]  S. Shafer,et al.  The Influence of Method of Administration and Covariates on the Pharmacokinetics of Propofol in Adult Volunteers , 1998, Anesthesiology.

[24]  T. Mashimo,et al.  Pulmonary Disposition of Propofol in Surgical Patients , 1998, Anesthesiology.

[25]  J Schüttler,et al.  Population Pharmacokinetics of Propofol: A Multicenter Study , 2000, Anesthesiology.

[26]  R. Upton,et al.  Epinephrine, norepinephrine and dopamine infusions decrease propofol concentrations during continuous propofol infusion in an ovine model , 2001, Intensive Care Medicine.

[27]  Kazuyuki Ikeda,et al.  Relation between Initial Blood Distribution Volume and Propofol Induction Dose Requirement , 2001, Anesthesiology.

[28]  M. Avram,et al.  Using Front-end Kinetics to Optimize Target-controlled Drug Infusions , 2003, Anesthesiology.

[29]  T. Kazama,et al.  Comparison of Predicted Induction Dose with Predetermined Physiologic Characteristics of Patients and With Pharmacokinetic Models Incorporating those Characteristics as Covariates , 2003, Anesthesiology.

[30]  R N Upton,et al.  The two-compartment recirculatory pharmacokinetic model--an introduction to recirculatory pharmacokinetic concepts. , 2004, British journal of anaesthesia.

[31]  Anthony G. Doufas,et al.  Induction Speed Is Not a Determinant of Propofol Pharmacodynamics , 2004, Anesthesiology.

[32]  Richard N Upton,et al.  A Physiologically Based, Recirculatory Model of the Kinetics and Dynamics of Propofol in Man , 2005, Anesthesiology.

[33]  Steven L. Shafer,et al.  Measuring the predictive performance of computer-controlled infusion pumps , 1992, Journal of Pharmacokinetics and Biopharmaceutics.

[34]  R. Sethuraman Chapter 133 – Intravenous Drug Delivery Systems , 2007 .

[35]  Steven L Shafer,et al.  Influence of Administration Rate on Propofol Plasma–Effect Site Equilibration , 2007, Anesthesiology.

[36]  N. Holford,et al.  Mechanism-based concepts of size and maturity in pharmacokinetics. , 2008, Annual review of pharmacology and toxicology.

[37]  M. Struys,et al.  Simulated Drug Administration: An Emerging Tool for Teaching Clinical Pharmacology During Anesthesiology Training , 2008, Clinical pharmacology and therapeutics.

[38]  Satoshi Hagihira,et al.  Early Phase Pharmacokinetics but Not Pharmacodynamics Are Influenced by Propofol Infusion Rate , 2009, Anesthesiology.